Galmed Pharmaceuticals Stock Forecast

Buy candidate since Jul 30, 2026 Gain 3.67%

The Galmed Pharmaceuticals Ltd. stock price gained 3.67% on the last trading day (Friday, 31st Jul 2026), rising from $0.599 to $0.621. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 14.89% from a day low at $0.541 to a day high of $0.621. The price has risen in 7 of the last 10 days and is up by 13.76% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 45 thousand more shares were traded than the day before. In total, 140 thousand shares were bought and sold for approximately $86.84 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.99% during the next 3 months and, with a 90% probability hold a price between $0.363 and $0.605 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GLMD Signals & Forecast

Mostly positive signals in the chart today. The Galmed Pharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.558 and $0.565. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 22, 2026, and so far it has risen 22.99%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Galmed Pharmaceuticals Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Galmed Pharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.550 and $0.534. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Galmed Pharmaceuticals Ltd. finds support just below today's level at $0.550. If this is broken, then the next support from accumulated volume will be at $0.534 and $0.469.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0805 between high and low, or 14.89%. For the last week, the stock has had daily average volatility of 13.85%.

Our recommended stop-loss: $0.598 (-3.74%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (GLMD) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Galmed Pharmaceuticals Ltd. to open at $0.594, and during the day (based on 14 day Average True Range), to move between $0.591 and $0.651, which gives a possible trading interval of +/-$0.0605 (+/-10.24%) up or down from last closing price. If Galmed Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 10.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.628 (1.10%) than the support at $0.550 (11.42%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Galmed Pharmaceuticals Ltd. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 1.463 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $0.594 ( 4.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk